Abstract
The Uniform Protocols for Imaging in Clinical Trials (UPICT) 18F-FDG PET/CT protocol is intended to guide the performance of whole-body FDG PET/CT studies within the context of single-andmultiple-center clinical trials of oncologic therapies by providing acceptable (minimum), target, and ideal standards for all phases of imaging. The aim is to minimize variability in intra-and intersubject, intra-and interplatform, interexamination, and interinstitutional primary or derived data. The goal of this condensed version of the much larger document is to make readers aware of the general content and subject area. The document has several main subjects: context of the imaging protocol within the clinical trial; site selection, qualification, and training; subject scheduling; subject preparation; imaging-related substance preparation and administration; imaging procedure; image postprocessing; image analysis; image interpretation; archiving and distribution of data; quality control; and imaging-associated risks and risk management.
Original language | English (US) |
---|---|
Pages (from-to) | 955-961 |
Number of pages | 7 |
Journal | Journal of Nuclear Medicine |
Volume | 56 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1 2015 |
Keywords
- Fluorodeoxyglucose
- Guideline
- PET CT
- Protocol
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging